Tampering with cellular fats holds great promise

October 26, 2018

Today, much of the biology underlying cells' compositions of lipids is a black box to scientists. Even though lipids are a major group of biomolecules, they are difficult to study because their synthesis is regulated by complicated metabolism.

Now, researchers from the Department of Energy's Joint BioEnergy Institute (JBEI), Berkeley Lab, and The Novo Nordisk Foundation Center for Biosustainability at Technical University of Denmark (DTU Biosustain) have found a way to engineer the fatty membranes of cells. The researchers boosted the cells' ability to produce high amounts of fluid fats, so-called unsaturated lipids. This increased the membrane respiration as well as the cell's growth rate.

This knowledge could be an advantage when engineering the cellular workhorses E. coli or baker's yeast to produce biofuels, biochemicals or biopharmaceuticals. Therefore, this method could become very important in industries working with cell factories.

The research has now been published in Science.

The researchers showed how to manipulate the lipid composition of E. coli and baker's yeast. The next step is to show that the method works for mammalian cells as well.

"The applications for future work aren't industrial, but rather related to health. Several diseases, such as type 2 diabetes, lead to more rigid membranes and also feature impaired mitochondria function," says first-author, Postdoc Itay Budin from JBEI.

Mitochondria are the cell's power plants. Cells with impaired mitochondrial function work slowly compared to normal cells. Making the cells' membrane more fluid could normalize mitochondrial function.

"We are excited about this work - it shows that synthetic biology and metabolic engineering can be applied to gain basic insights in fundamental biological processes. This basic knowledge is very important in order to develop new treatments for diseases that we basically don't understand the mechanisms behind," says co-author, Professor at JBEI and Scientific Director at DTU Biosustain Jay Keasling.
-end-


Technical University of Denmark

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.